We are proud to announce, Jim Keith, CSO of EmstoPA as Keynote Speaker at the Virtual Precision in Drug Discovery & Preclinical Summit on Thursday, July 23rd. He will be discussing “Exploring EmstoPA-The First Specific Treatment for tPA-Induced Bleeding”
https://www.linkedin.com/posts/precision-evolution-global-inc_virtualpddp-pct-precisionevents-activity-6687433856292851712-lyI_

A new report from GlobalData shows that the stroke market is about to experience growth across the eight major markets as a result of increasing population, especially in China.

https://www.pharmaceutical-technology.com/comment/population-boom-will-boost-acute-stroke-market-particularly-china/

CEO, Charles Phillips, will be at #bioeurope next week. Reach out to us if you’d like a meeting to discuss EmstoPA, the novel tpa antidote.

The EmstoPA team had a great time at #RESIBOS17. If you missed us there, visit http://www.emstopa.com to find out more!

Stroke deaths are on the rise, at the rate of 4% per year, according to a new report from the CDC – https://goo.gl/3np4YA

Load More…

“Major changes in stroke care can save lives”

  This is a timely article from the NHS that documents the improvements in stroke care in the United Kingdom. However, it points out that “It’s a shocking fact that…
Read More